Skip to main content

Table 1 Eligibility criteria

From: Optimization of the viability of stem cells derived from umbilical cord blood after maternal supplementation with DHA during the second or third trimester of pregnancy: study protocol for a randomized controlled trial

Inclusion criteria

Exclusion criteria

Caucasian

When it is impossible to collect cord blood (bureaucratic reasons or because of emergencies regarding the health of the mother or the baby)

Non-smokers

Women who have taken other supplements containing DHA or fish oil

Over 18 years of age

Mother with a temperature of 39°C during delivery

Single pregnancy

UCB samples with a volume of less than 80 ml and/or less than 70% cell vitality

Absence of diabetes or hypertension, or any other type of pathology requiring pharmacological therapy

 

Absence of chromosome abnormalities and/or congenital malformations in the foetus

 

HBV, HCV, HIV and CMV negative

 
  1. CMV, cytomegalovirus; DHA, docosahexaenoic acid; HBV, hepatitis B virus; HCV, hepatitis C virus; UCB, umbilical cord blood.